136 related articles for article (PubMed ID: 7878922)
1. Effect of posttransplant cyclosporine treatment on the development of syngeneic GVHD in recipients of UV-B irradiated bone marrow cells.
Ohajekwe OA; Hardy MA; Oluwole SF
Transplant Proc; 1995 Feb; 27(1):1385. PubMed ID: 7878922
[No Abstract] [Full Text] [Related]
2. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
3. Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells.
Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
Transplant Proc; 1993 Feb; 25(1 Pt 1):475-6. PubMed ID: 8438384
[No Abstract] [Full Text] [Related]
4. UVB-irradiated bone marrow allografts in rats: induction of unresponsiveness for long-term heart allografts without GVHD.
Wasfie T; Chabot J; Pepino P; Tezuka K; Hardy MA
Transplant Proc; 1990 Aug; 22(4):2011-2. PubMed ID: 2389512
[No Abstract] [Full Text] [Related]
5. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Hess AD; Horwitz LR; Laulis MK
Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
[No Abstract] [Full Text] [Related]
6. The mechanism of UVB prevention of graft versus host disease.
Greenfeld JI; Chabot JA; Oluwole SF; Hardy MA
J Surg Res; 1996 Jan; 60(1):137-41. PubMed ID: 8592404
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.
Glazier A; Tutschka PJ; Farmer ER; Santos GW
J Exp Med; 1983 Jul; 158(1):1-8. PubMed ID: 6345713
[TBL] [Abstract][Full Text] [Related]
8. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
[TBL] [Abstract][Full Text] [Related]
9. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
[TBL] [Abstract][Full Text] [Related]
10. Review of vascularized bone marrow transplantation: current status and future clinical applications.
Gordon CR; Tai CY; Suzuki H; Strande LF; Ramsamooj R; Matthews MS; Black KS; Hewitt CW
Microsurgery; 2007; 27(4):348-53. PubMed ID: 17477415
[TBL] [Abstract][Full Text] [Related]
11. Prevention of GVHD by modulation of rat bone marrow with UV-B irradiation: II. Kinetics of migration of UV-B-irradiated bone marrow cells in naive and lethally irradiated rats.
Oluwole SF; Engelstad K; Hardy MA
Cell Immunol; 1990 Jun; 128(1):289-300. PubMed ID: 2344623
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum.
Oluwole SF; Engelstad K; Hardy MA
Transplant Proc; 1992 Dec; 24(6):2858-9. PubMed ID: 1465974
[No Abstract] [Full Text] [Related]
13. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant.
Tai CY; Strande LF; Eydelman R; Sheng X; VanTran JL; Matthews MS; Hewitt CW
Transplantation; 2004 Jan; 77(2):316-9. PubMed ID: 14743002
[TBL] [Abstract][Full Text] [Related]
14. Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A.
Liem LM; van Noort JT; Goulmy E
Bone Marrow Transplant; 1996 Jul; 18(1):73-8. PubMed ID: 8831998
[TBL] [Abstract][Full Text] [Related]
15. Acute skin GVHD following syngeneic BMT for CLL.
Deane M; Singer C; Lawler M; McElwaine S; Gomez K; Prentice HG
Bone Marrow Transplant; 1998 Dec; 22(12):1207-9. PubMed ID: 9894725
[TBL] [Abstract][Full Text] [Related]
16. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
[TBL] [Abstract][Full Text] [Related]
17. UVB irradiated allogeneic bone marrow transplantation in rats: prevention of graft versus host disease without immunosuppression.
Pepino P; Hardy MA; Chabot JA; Berger C; Marboe C; Wasfie T
Transplant Proc; 1989 Feb; 21(1 Pt 3):2995-6. PubMed ID: 2523168
[No Abstract] [Full Text] [Related]
18. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
Hess AD; Jones RC; Santos GW
Bone Marrow Transplant; 1993; 12 Suppl 3():S65-9. PubMed ID: 8124261
[TBL] [Abstract][Full Text] [Related]
19. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
20. Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP).
Hess A; Thoburn C; Bright E; Horwitz L
Transplant Proc; 1997; 29(1-2):725-7. PubMed ID: 9123499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
